1. Home
  2. Bills
  3. H.R. 10369

H.R. 10369 · 119th Congress · 2025–2026

Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

H.R. 10369 in the 119th Congress (2025–2026) was introduced on Sep 14, 2026, sponsored by Ryan Mackenzie with 4 co-sponsors.

During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.

Status
Introduced
Introduced
Sep 14, 2026
Co-sponsors
4
Policy area
Health

Sponsor

Ryan Mackenzie (R-PA). Co-sponsors: 2 Democrats, 2 Republicans.

Where it stands

  • IntroducedSep 14, 2026
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each c (Sep 14, 2026)

More bills from Ryan Mackenzie in the 119th Congress

Other Health bills in the 119th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 10369 (119th Congress): Net Effective Cost Transparency and…,” https://www.capitolreceipts.com/bill/119-hr-10369/net-effective-cost-transparency-and-prescription-drug-affordability-ac (accessed 2026-10-17).